NCT00304291 2020-12-28A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)State University of New York at BuffaloPhase 4 Completed5 enrolled
NCT02276963 2019-06-06Ublituximab for Acute Neuromyelitis Optica (NMO) RelapsesJohns Hopkins UniversityPhase 1 Completed6 enrolled 9 charts
NCT00501748 2011-09-27Safety and Tolerability of Rituximab in Neuromyelitis OpticaUniversity of California, San FranciscoPhase 1 Completed20 enrolled